Yubo International Biotech Ltd (YBGJ) stock
YBGJOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.01+0.00 (0.00%)
Close on Oct 16, 2026Market cap $886.19KP/E –Yield –
Yubo International Biotech profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Yubo International Biotech's profit margin for the twelve months ending Jun 30, 2026 was -8157.3%. For fiscal 2026 it was -8736.7%, against -51171.4% the year before. The highest annual figure on record is -124.0% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | Dec 31, 2025 | -8736.7% | +42434.7 |
| FY2025 | Dec 31, 2024 | -51171.4% | −50973.8 |
| FY2024 | Dec 31, 2023 | -197.6% | +957.9 |
| FY2023 | Dec 31, 2022 | -1155.5% | −1031.6 |
| FY2022 | Dec 31, 2021 | -124.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2026CQ4 2025 | Dec 31, 2025 | -1432.5% | +24254.7 |
| Q1 FY2025CQ1 2024 | Mar 31, 2024 | -10817.0% | −10614.8 |
| Q4 FY2024CQ4 2023 | Dec 31, 2023 | -2321.6% | −2477.3 |
| Q3 FY2024CQ3 2023 | Sep 30, 2023 | 1.5% | +1634.5 |
| Q2 FY2024CQ2 2023 | Jun 30, 2023 | -25687.2% | −19519.6 |
| Q1 FY2024CQ1 2023 | Mar 31, 2023 | -202.2% | +3603.4 |
| Q4 FY2023CQ4 2022 | Dec 31, 2022 | 155.8% | +275.3 |
| Q3 FY2023CQ3 2022 | Sep 30, 2022 | -1633.0% | −1290.6 |
| Q2 FY2023CQ2 2022 | Jun 30, 2022 | -6167.6% | – |
| Q1 FY2023CQ1 2022 | Mar 31, 2022 | -3805.6% | – |
| Q4 FY2022CQ4 2021 | Dec 31, 2021 | -119.5% | – |
| Q3 FY2022CQ3 2021 | Sep 30, 2021 | -342.4% | – |
See a number that looks wrong?